Medecins sans Frontieres (Doctors without Borders) provide emergency medical treatment to people all over the world, who would otherwise be left with no, or extremely paltry medical care. MSF treat many patients with HIV/AIDS in developing countries. More than 80% of the drugs they use are produced in India. (The same is true of other medicines used by MSF.) But the European Commission is attempting to halt the use of cheap, generic medicines. This will result in the deaths of millions of people, who cannot afford the vastly more expensive, branded versions. The European Commission’s actions include:
- Pushing for provisions in free trade agreements that will halt the production of affordable generic medicines.
- Detaining generic medicines that are in transit through Europe on their way to patients in developing countries.
- Pushing for restrictions on production and supply of generic medicines through anti-counterfeiting policies like ACTA, the secretive international anti-counterfeiting trade agreement.
The campaign page is here if you want to get involved.
Here’s a short video of patients in Kenya who rely on generic medicines.